Mario Alberto ACCARDI · 2015-11-13 · Mario Alberto ACCARDI Associate Entrepreneurs Fund Management United Kingdom Previous investments in digital health Minimum ticket amount (in

Mario Alberto is an Associate at the

Entrepreneurs Fund where he focuses on

early stage investments in both the life

sciences and technology sectors. Mario is also

co-founder of Sierra MedTech, an angel

backed medical technology start-up.

Previously, he was working as a strategy

consultant in the life sciences sector. Mario

holds a PhD in Biomedical Engineering and a

First Class Honours degree in Mechanical

Engineering from Imperial College London.

Mario Alberto

ACCARDI

Associate

Entrepreneurs Fund

Management

United Kingdom

Previous investments

in digital health

Minimum ticket amount (in €)

200,000

Maximum ticket amount (in €)

3,000,000

Health 2.0 categories of interested

This project has received funding from the European Union’s Seventh

Framework Programme for research, technological development and

demonstration under grant agreement no 611709


●Consumer Facing Solutions

●Self-Management Tools & Trackers

●Personal Health Assessment &

Diagnostic Testing

●Clinical Trials Search & Recruitment

●Professional Facing Solutions

●Professional Knowledge Exchange

●B2B Clinician Workflow

●Data Exchange and Analytics

●B2B Decision Support & Analytics

Dr. Razouki is the current Chief Business

Development Officer of Kuwait Life Sciences

Company (KLSC) where he is responsible for

identifying new business opportunities for all

KLSC subsidiary companies as well as

sourcing investments opportunities for KLSC

corporate. Dr. Razouki is a regional thought

leader within the Middle East life sciences

industry having himself shifted from an

excellence in clinical practice and research to

the management and financing of healthcare

systems.

Dr. Mussaad AL-

RAZOUKI

Chief Investment Officer

Kuwait Life Sciences

Company

Kuwait


in digital health


1,000,000


3,000,000









●Financial Management

●Patient Communities

●Content


●B2B Administrative Tools

●B2B Revenue Collection

●Patient Provider Communication


As founding partner and manager of Avet

Ventures, Felix brings his experience as an

entrepreneur, extensive expertise in different

companies and more than 10 years working

as a VC.

Felix ARIAS

General Partner

Avet Ventures

Spain


in digital health


500,000


4,000,000





We invest in and grow promising and

passionate early-stage MedTech & Digital

Health ventures. We take a structured,

hands-on approach to build next

generation products

Karsten BAGGER

Founding partner

Health Disrupt

Switzerland


in digital health


50,000


3,000,000


● Consumer Facing Solutions

● Self-Management Tools & Trackers

● Personal Health Assessment

& Diagnostic Testing

● Clinical Trials Search &

Recruitment

● Wellness

● Data Exchange and Analytics




Juan Antonio

BECEIRO FRIEDMANN

CMO

37celsius capital

partners

USA


in digital health


1,000,000


N/C



●Gaming









Currently in the process of setting up a

new fund to focus specifically on digital

health solutions for the prevention of long

term chronic conditions.

Rosie CUNNINGHAM

THOMAS

CEO

Artemis Healthcare

Ventures

United KingdomPrevious investments

in digital health

Currently in the process of

setting up a new fund to focus

specifically on digital health

solutions for the prevention of

long term chronic conditions.


N/C


N/C




● Content

● B2B Clinician Workflow





10 years of experience working in Assurance

and M&A advisory at KPMG Transaction

Services, where he advised clients on over 50

M&A deals, including cross-border

transactions in the US and Europe. MBA

(IESE), CA and B.Com (Honours) from Shri

Ram College of Commerce, Delhi University.

Varun DALAL

Principal

THCAP

Spain


in digital health

Practice Fusion

Ringadoc

Medical Envelope d/b/a ME911


N/C


N/C








Diagnostic Testing



Inga is an Associate in the Healthcare

Ventures team specialising in investments

across medical devices, therapeutics, and

diagnostics, including digital health. She

observes on the boards of

PsychologyOnline and Puridify. Previously

she worked at the London Bioscience

Innovation Centre/RVC commercializing

research, sourcing and building industry

collaborations. She completed a DPhil and

MSc in Neuroscience from the University of

Oxford, sponsored by the Wellcome Trust,

developing translational models of disease.

Her first degree was Natural Sciences from

the University of Cambridge.

Inga DEAKIN

Associate

Imperial Innovations


in digital health

We are actively investigating

investments in digital health. Last

year we invested in PsychologyOnline

which is a digital health company

delivering live online one-to-one

cognitive behavioural therapy. The

system securely connects a patient to

a psychotherapist for an instant

messanger style therapy session and

is currently available in a number of

areas via the NHS. We are looking for

companies addressing a real unmet

need, with measurable benefits, with

differentiating technology and

experience, with defined routes to

market and significant opportunity to

scale.

Minimum ticket amount (in €) : N/C

Maximum ticket amount (in €) : N/C




●Personal Health Assessment


●Coaching & Advisory Services




●Search

●Content

●Gaming

●Wellness

●Provider Search








●Data Utility Layer


●Privacy & IdentityThis project has received funding from the European Union’s Seventh



Michael Dimitropoulos is Investment

Manager of the Piraeus VC-PE Group with

technology focus. He previously served as

Head of Research.

Michael joined Piraeus Bank Group in

2001. He was Director of Research &

Investment Strategy at Hellenic

Investment Company until 2005 and

worked as a Senior Investment Officer in

Piraeus Bank’s Wealth Management,

before joining the VC-PE Group in 2009.

Previously, he worked as Investment

Associate at Global Finance, Head of

Research at Eurocorp and Chief Analyst

at National Securities.

Michael

DIMITROPOULOS

Investment Manager

PJ Tech Catalyst

Greece


in digital health


N/C


750,000





Janke Dittmer is investing in MedTech,

Diagnostics and Digital Health. Prior to

Gilde, he was a Venture General Manager

at Philips Healthcare's Corporate

Venturing unit, responsible for strategy

and new investments and lead several

ventures. Janke was an Engagement

Manager at McKinsey&Co. advising

clients on growth strategies. Janke

cofounded a Nanotech company in the

Silicon Valley, served as a Fellow at LBL

and was a Post-Doc at UC Berkeley.

Janke earned a PhD in Physics from the

University of Cambridge.

Janke DITTMER

Partner

Gilde Healthcare

The Netherlands






●Wellness











in digital health

Definiens (2012)


3-5,000,000


15-20,000,000

Tim Dolman joined Noaber in 2013. As

investment manager Tim is responsible

for a portfolio of investments and

identifies & evaluates opportunities.

Having finished his Finance Master in

2009, he started at SNS Securities. In

one year he completed the Investment

banking traineeship, followed by a

position in which he advised institutional

investors on their European equity

investments. After more than three years

he resigned to start his own company in

online payment authentication. Tim is

Certified European Financial Analyst.

Tim DOLMAN

Investment Manager

Noaber Ventures

The NetherlandsPrevious investments

in digital health

Noaber Ventures is the impact

investing, healthcare technology

Venturing arm of the Noaber

Foundation. Noaber invest in

disruptive innovations that contribute

to the Vitality and Independency of

people and/or smart delivery of

healthcare. Noaber initiated

breakthrough innovations in areas

like disease chain management,

diagnostic tools and online

interventions. Noaber provides seed,

early stage and growth capital.


100,000


2,500,000



● Self-Management Tools &

Trackers

● Personal Health Assessment &

Diagnostic Testing

● Patient Communities

● Content

● Gaming

● Wellness


● Patient Provider Communication


● B2B Decision Support & Analytics




Peter works for Entrepreneurs Fund, the

venture capital member of COFRA, a

global family-controlled group of

businesses. EF manages approximately

€240 million of committed capital across

two funds, which it invests in early stage

and growth companies across the life

sciences and other technology sectors.

Peter previously worked as a consultant

for big pharma and biotech, with a

specific emphasis on biological

therapeutics. Prior to that he was a

postdoctoral research fellow at the

University of Oxford.

Peter DUDEK

Associate

Entrepreneurs Fund


in digital health

No investments in digital health.

Lots of investments in the

healthcare space though -

currently in the portfolio:

Prosonix (£30m+ raised),

Optinose ($150m raised), Cytoo

(€15m raised), Sequana Medical

(CHF 60m+ raised), Vasopharm

(€25m raised), Lifeline Scientific,

t2cure (€10m+ raised).


200,000


12,000,000






Diagnostic Testing

● Clinical Trials Search & Recruitment

● Professional Facing Solutions




Lead healthcare partner at Albion Ventures

where he focuses on medical technologies

and technology-enabled services to the

healthcare and life-science sectors. Initially

practiced as a surgeon, specialising in

neurosurgery, before joining the Boston

Consulting Group (BCG), where he

specialised in healthcare strategy, including

biotechnology, pharmaceuticals, service

and care providers, software and

telecommunications. Graduate of

Cambridge University and Fellow of the

Royal College of Surgeons. Serves on the

boards of companies ranging from

diagnostics, imaging and software to

pharmaceuticals and biomarkers.

Andrew ELDER

Partner

Albion Ventures LLP

United Kingdom


in digital health

Mirada Medical

My Meds & Me

Cisiv

Aridhia Informatics


1,000,000


10,000,000






Diagnostic Testing


Recruitment


● Facing Solutions


● Collection Patient Provider

● Communication Data Exchange

and Analytics

● Decision Support & Analytics

I qualified in Botany with Biochemistry,

majoring on genetics, but then worked in

domestic and international banking in

NatWest and Standard Chartered, dealing

with the Asia Pacific Region in the latter.

I joined Highlands and Islands Enterprise

in economic and social development,

covering general business development,

then managing a business start up

programme, before focussing on

commercialising R&D. I now oversee oiur

investment activities and accessing

external sources of funding, having

acquired some knowledge of state aids

along the way.

Jeff FOOT

Head of External Funding

& Investment

Highlands and Islands

Enterprise

Scotland, UK


in digital health

Highlands & Islands Enterprise has

investments in a small number of digital

health SMEs, ranging from software &

web management to development of

self-diagnostic consumables, but we also

provide support to existing businesses

and teams spinning out businesses from

academia and the NHS. A key form of

help is facilitating investor readiness and

where necessary sharing the risk with

the private sector, either by co-investing

or co-lending. In addition, we access

advice, information and contacts through

networks (including Scottish

Development International's offices in 60

teritorries and our own office in Brussels)

to help businesses develop links with

potential investors, suppliers, clients or

for collaborative developments.



●· Self-Management Tools & Trackers

●· Personal Health Assessment &

Diagnostic Testing

●·Patient Communities

●· Gaming

●· Wellness

●· Professional Facing Solutions

●· B2B Administrative Tools

●· Data Exchange and Analytics This project has received funding from the European Union’s Seventh



From 2009, 50 digital health

organisations have developed here,

covering clinical informatics, diabetes

management, digital design, health &

well-being services, health delivery,

risk management, medical devices

and diagnostics. Our aim is to grow

these as fast as possible to maximise

their economic and social impact.

Carlos provides support to Ysios, particularly

for identifying and evaluating investment

opportunities in Digital Health and MedTech.

Carlos has over 12 years of experience in the

pharmaceutical industry working

internationally in several countries, including

the US, Spain, and UK. Carlos has held

managerial responsibilities at Pfizer and

Almirall, in Licensing, Business Development

and Country Management. In his tenure as

Almirall M&A Director, Carlos was responsible

to negotiating strategic company and product

acquisitions. More recently Carlos was

appointed Country Manager for UK & Ireland,

where he was responsible to set up from

scratch and subsequently manage the

company operations in these key countries.

Carlos GALLARDO

Venture Partner

YSIOS CAPITAL

Spain


in digital health

Yoogaia


500,000


1,500,000





Diagnostic Testing



●Search

●Provider Search






Amanda GETT

Investment Manager

Roche

Switzerland


in digital health


N/C


N/C







Trackers


Diagnostic Testing


Recruitment


● Content

● Gaming




● B2B Decision Support &

Analytics

20-year experience in corporate finance, M&A

and venture capital at E&Y, PwC, HVA,

Barcelona Stock Exchange. Board member of

both public and start-up technology

companies. B.S. Business Administration

(University of Barcelona), MBA (University of

San Francisco).

Luis GUTIERREZ ROY

Managing Partner

THCAP

Spain


in digital health

Practice Fusion

Ringadoc

Medical Envelope d/b/a ME911


N/C


N/C








Diagnostic Testing



Lennart’s interest in social impact

investment and early stage businesses

led him from the dark side of finance to a

role as an investment manager at the

Foundation for Social Entrepreneurs and

on to Social Venture Fund, the largest

Pan-European Social Impact Venture

Capital provider. Here he is responsible

for investments in the rapidly evolving UK

market and spans across sectors,

including health, education and financial

inclusion, often with a tech bias.

Lennart HERGEL

Investment Director

Ananda / Social

Venture Fund

Germany


in digital health


1,000,000


3,000,000





Bo has more than two decades of experience in

venture capital, investment management,

fundraising, organizational and strategic

development as well as sales and marketing.

Having lived and worked in the UK, Italy, France,

Switzerland, Finland, Spain and Singapore, he

comes with a global view to business. Bo began

his career in the telecom infrastructure

business with Alcatel and Nokia where he

launched some of the first GSM networks in the

world and negotiated GSM supply contracts in

Europe and South East Asia. In 2002 he joined

Vertex Management, where he managed several

investments with successful M&A transactions

generating in excess of $300 million. Bo has

also started two companies and raised money

for an investment fund focused on Eastern

Europe.

Bo ILSOE

Partner

Nokia Growth Partners

Finland


in digital health

Yoogaia


N/C


N/C





Min-Sung is a Partner at XLHEALTH, a

Berlin-based Venture Capital fund

specialized on Digital Health investments.

He founded his first business in 2011

and conducts seed investments with

Lakeside Ventures since 2013. Min-Sung

studied in Witten, Seoul, St. Gallen, and

Cambridge (MA) and received a

scholarship from the Foundation of

German Businesses.

Min-Sung Sean KIM

Partner

XLHEALTH AG

Germany


in digital health

NeuroNation

MySugr

Harimata

Onlife


200,000


5,000,000




● Coaching & Advisory Services


● Gaming

● Wellness




Miles is currently Managing Director of

Qualcomm Ventures Europe. Miles leads

investments, works closely with portfolio

companies to add value and investigates

new investment areas and opportunities

for Qualcomm in Western and Eastern

Europe. Miles currently represents

Qualcomm Venture’s investments in

Formula E, Fon, ip.access, Call Sign,

Voluntis and Anteryon.

Miles received his MBA from University of

California, Irvine in the US and a

bachelor's degree in Electronic and

Communications Engineering from Bristol

University, UK.

Miles KIRBY

Managing Director

Qualcomm Ventures

United Kingdom


in digital health

Portfolio companies in this space

include: Airstrip, AliveCore, Clear

Care, Common Sensing, Edico

Genome, Fitbit, GoBalto, Practice

Fusion, Telcare and Welltok.


200,000


10,000,000





Diagnostic Testing





●Search

●Content

●Gaming

●Wellness

●Provider Search





● B2B Revenue Collection



● Data Utility Layer

● Privacy & Identity


Analytics




Piotr runs RTAventures VC, VC fund

focused on online and healthcare related

businesses. RTAventures invested in

Docplanner, Typeform, inFakt, Voxel and

also Point Nine Fund II. Previously, Piotr

worked with Enterprise Investors, a

leading private equity player in CEE,

where he originated and completed

investment in Polish Stem Cell Bank, one

of the top 3 leading cord blood banks in

Europe. Earlier he ran his own advisory

boutique for 7 years advising on

acquisitions in the CEE region.

Piotr KULESZA

General Partner

RTAventures VC

PolandPrevious investments

in digital health

Docplanner (2012) - marketplace

for finding and booking medical

appointment online

(www.docplanner.com).

Voxel (2012) - leading chain of

diagnostic imaging centres in

Poland.


100,000


1,000,000








Diagnostic Testing

●Clinical Trials Search &

Recruitment



●Search

●Content

●Provider Search









●Privacy & Identity

●B2B Decision Support

& Analytics

Ravi loves disruptive technologies & disruptive

business models. He loves the buzz and

energy of Start-Ups and is passionate about

Healthcare and IT. Value creation drives him.

He is Chairman of the Board at ZANEC, an

innovative software R&D business, focused on

software Research and Development with an

innovative business model of RDaaS (R&D as

a Service) with an emphasis on R part of the

R&D. They invest and provide R&D in return

for equity.

Ravi KUMAR

Chairman

ZANEC

United Kingdom


in digital health

Zanec has invested and nurtured

a number of start-ups in

Technology, Healthcare, Patient

Safety, Patient Engagement.


N/C


N/C





• Self-Management Tools & Trackers

• Patient Communities

• Wellness

• B2B Clinician Workflow

• Patient Provider Communication

• B2B Decision Support & Analytics

Marc Lambrechts is Senior Investment

Manager at Capricorn Venture Partners.

New investments are made out of the

Capricorn ICT Fund with a focus on digital

healthcare and big data. Prior to joining

Capricorn Venture Partners, Marc was a

senior scientific advisor at IWT and

section head with the R&D division of

Terumo Europe. He has a PhD in

Microelectronics from the University of

Leuven, with a specialisation in

biosensors.

Marc LAMBRECHTS

Senior Investment

Manager

Capricorn Venture

Partners

BelgiumPrevious investments

in digital health


250,000


1,500,000







Trackers


Diagnostic Testing



Recruitment


● Content

● Wellness


● Professional Knowledge Exchange







Analytics

Wlodek is a co-founder of Nomad Fund,

where he leads investments in early and

mid stage ICT, Fintech, IoT & HealtTech

companies. He is interested in SaaS &

mobile space.

Previously he worked with CEE

companies (established in Western

Europe, but their ops / R&D located in

CEE), helping with fundraising and exits.

He is an entrepreneur (co-founded, led to

exit) and an ex-investment banker.

Born in Poland, spend most of his life in

London; proud alumni of the LSE.

Wlodek LASKOWSKI

Partner

Nomad Fund

Poland


in digital health

Evidence Prime Inc.., a founder

investor

DrOmnibus Ltd. - current Fund

investment being finalised

InferMedica - negotiting an

investment


500,000


1,500,000



●· Search

●· Gaming

●· Professional Facing Solutions

●· Professional Knowledge Exchange

●· B2B Clinician Workflow

●· Patient Provider Communication

●· Data Exchange and Analytics

●· Data Utility Layer






Sven is co-founder and managing partner of

Endeavour Vision. In 1996, he co-founded

Vision Capital, a Trans-Atlantic technology

venture capital firm with offices in Silicon

Valley and Geneva. With 20 years of Venture

Capital experience, Sven has developed an

extensive international network. This network

of contacts was leveraged through the

European Tech Tour Association that he

founded in 1998. Sven, was recognised for

his contribution in shaping the European

technology ecosystem through a number of

awards and featured in international

publications.

Sven LINGJAERDE

Managing Partner

Endeavour Vision SA

Switzerland


in digital health

Sophia Genetics


N/C


N/C







Diagnostic Testing






Walter brings more than 10 years of

consumer internet and mobile technology

experience to NGP from both large

organizations and smaller startups.

Walter focuses on investments in media

and entertainment globally, including

gaming and education technology. His

board responsibilities include Babbel,

Grand Cru and MAG Interactive.

Prior to joining NGP in 2010, he worked

in strategy and business development at

Nokia, including corporate M&A and

business development in Nokia’s games

division. Before joining Nokia in 2008, he

helped launch a social networking start-

up where he led international business

development.

Walter MASALIN

Principal

Nokia Growth Partners

Finland


in digital health

Yoogaia


N/C


N/C





Stephane has invested in the life science

sector for nearly 15 years in seed and

growth capital. Previously he worked for

GSK in business development.

Stephane MERY

Partner

Beringea LLP

United Kingdom


in digital health

Digital Healthcare Ltd


N/A


N/A



●· Self-Management Tools & Trackers

●· Personal Health Assessment &

Diagnostic Testing

●· Coaching & Advisory Services


●· Patient Communities

● Content

● Wellness




● B2B Administrative Tools





● B2B Decision Support & Analytics This project has received funding from the European Union’s Seventh



JHI is a venture and incubation unit that

aspires to accelerate the transformation

of Johnson & Johnson from a product-

centric company to a broader healthcare

solutions company.

• Marco’s expertise is in commercial

strategy, general management and

healthcare innovation.

• He offers a unique perspective on how

pharmaceutical companies can and

should engage in cross-industry

collaborations, open innovation and

integrated care models in the pursuit of

new revenue streams.

Marco MOHWINCKEL

Global Head Integrated

Care Solutions

Janssen Healtchare

Innovation

United Kingdom


in digital health


N/C


N/C




Diagnostic Testing


● Financial Management


● Content

● Wellness








Monique is a Senior Investment Officer in the

IFC Venture Capital group with 20 years of

experience in the health sector. She leads

investments in venture companies that offer

innovative health technologies or business

models with impact potential in emerging

markets. IFC, a member of the World Bank

Group, is the world’s largest multilateral

financier of the private sector in emerging

markets with an active portfolio of over $60

billion, comprising investments in 1,800

companies located in over 100 countries.

Monique MRAZEK

Senior Investment

Officer

World Bank Group/

IFC Venture Capital

USA


in digital health

IFC has made over $3bn of

investments in the health sector

globally since 1998. Two-thirds

of the portfolio is invested in

health service providers and the

remainder in life science and

medtech companies. Digital

health is a new invetment space

for IFC but one which brings

together IFC's health and IT

businesses. On the venture side,

IFC has made 73 investments

with over $640m invested.


4,000,000


No maximum







Diagnostic Testing











Fabrice is founder & CEO of Wellfundr, first

French crowdfunfing platform dedicated to

health.

Fabrice NABET

CEO Founder

WELLFUNDR

France


in digital health

Projects on their website :

https://www.wellfundr.com/fr


500 - Crowdfunding


16,000 - Crowdfunding








Diagnostic Testing





●Search & Content

●Gaming

●Wellness

●Provider Search










https://www.wellfundr.com/fr


in digital health

CareLigo AB, 2013, 2,5 MSEK.

CareLigo provides a service based

on a mobile platform to improve

selfcare behaviour in Heartfaliure

patients. The system is validated in

a prospectiive randomized clinical

trial and CE marked.

MedUniverse AB, 2014, 1,5 MSEK

Has a SaaS slution for creation,

distriution, interaction and

evaluation of Patient Cases for

education and market research

among medical proffesionals.


25,000


1,000,000

Investment manager for Almi Invest

active particularly in seed phase and

medtech companies.

Almi Invest invests in Swedish growth

companies.

Previous experience + 25 years in

Medical devices as sales and marketing

director for Elekta working with

Neurosuregery and Radiotherapy as well

as St Jude Mediccal in the field of

Cardiology.

Per NORDSTRÖM

Investment Manager

Almi Invest

Sweden




Diagnostic Testing






10+ Strategic partnerships experience

from the private sector (Intel, Agfa) and

the public sector (Ministry of Finance).

Currently managing strategic partnerships

in Healthcare

Shiran NUSBAUM

Strategic Partnerships

Manager

Agfa

France


in digital health


N/C


N/C















Daniel is director of Capital Cell, a biotech &

Life Sciences investment site. Through Equity

Crowdfunding Capital Cell proposes a

marketplace where everyone can invest in

tomorrow's pharma and health care

companies. Daniel is also founder of

Creoentuproyecto.com, offering equity

crowdfunding consulting, tech development,

legal advice and fund raising.

Daniel OLIVER

Director

Capital Cell

Spain


in digital health

Iproteos, drug discovery: 100K,

nov. 2014

ZeClinics, clinical research,

100K, may 2015


1000 - Crowdfunding


25000 - Crowdfunding





Diagnostic Testing





●Search& Content

●Wellness













Sergi is an experienced executive and

entrepreneur who has developed and run

technical companies providing people care

solutions in over 10 countries during 12 years.

Always open to search for digital technology-

driven opportunities for any core business

that will ensure it successfully meets the real

world challenges of its dynamic market place.

Sergi PALLARES

Partner & Advisor

Capital Cell

Spain


in digital health

Capitall Cell Equity crowdfunding

site for seed and start up .

companies in 'life science' field.


1000 - Crowdfunding


25000 - Crowdfunding





Diagnostic Testing





●Search& Content

●Wellness













Before joining Innovation Capital in 2008,

Florian was the CFO of listed Paris-based

biotech DBV Technologies.

Prior to that, he worked at Apax Partners,

and as an equity analyst at Schroder

Salomon Smith Barney (Citigroup)

covering the medtech and healthcare

services sectors.

Prior to that he was a doctor working

in the UK’s National Health Service

(Accident + Emergency and Internal

Medicine).

Florian holds a medical degree from

Imperial College London and a BA (hons)

in Physiology from Oxford University.

Florian REINAUD

Partner

Innovation Capital

France


in digital health

Voluntis (Suresnes, France).

Co-led €21m round in April 2014

Fitting Box (Toulouse, France),

led €2m in May 2014


500,000


5,000,000







● Content

●Gaming









Christoph is a partner at Albion Ventures

focusing on Healthcare. He has worked

for Bain & Company, 3i and GE

Healthcare before joining Albion Ventures

in 2011. He is a trained medical doctor

and has an MBA from INSEAD.

Christoph RUEDIG

Partner

Albion Ventures

United Kingdom


in digital health


1,000,000


10,000,000












Josep focuses on medtech investments and

on structuring transactions. He serves on the

board of MedLumics, Dermalumics and CVRx.

Formerly, he was board observer at

Endosense and board member at Sabir

Medical. Josep has over 15 years of

experience in law, corporate finance and

business development in connection with

entrepreneurs and with intellectual property-

related companies. Before joining Ysios, he

worked for the pharma and healthcare

industries, in business and corporate

development. He also worked at Cuatrecasas,

KPMG and Eurohold Corporate Finance,

where he was involved in mergers and

acquisitions, and financing of innovation and

technology.

Josep SANFELIU

Managing Partner

YSIOS CAPITAL

Spain


in digital health

Yoogaia


1,000,000


3,000,000





Diagnostic Testing



●Search

●Provider Search






Stephen Seuntjens, is a Partner in PHS, a

venture firm investing in businesses in

the area of health &wellbeing. He has

over 20 years of global experience in

developing new businesses. Companies

he has supported include Mind CTI, and

Israeli-based, Nasdaq-listed software

billing provider; Shapeways, as US based

portal company allowing creatives to

realize their objects through 3D printing

and Directlife, a Dutch company part of

Royal Philips Electronics, motivating

individuals to become more physically

active through monitoring and coaching.

Steve SEUNTJENS

Partner

PHS

The Netherlands


in digital health


N/C


N/C








●Wellness





Financial exec, turned entrepreneur, turned

venture capitalist. Stanislav has more than 10

years’ experience in the financial industry,

managing project and building new

businesses inside the corporate world.

In 2008 he left his fast growing career at

Allianz, raised an angel round to build his own

startup – market place for small business

lending. Learning some lessons the hard way,

he ended managing the biggest business plan

competition in Bulgaria – Empower Award,

wherefrom joining the LAUNCHub team was

the most logical thing to do.

Stanislav is a big fan of data driven decisions

and happy to be a connector for LAUNCHub

portfolio companies.

Stanislav SIRAKOV

Partner

LAUNCHub seed fund

Bulgaria


in digital health

Mediately – 100K in 2013

GreenPie - 50k in 2013

Kinestica - 200k in 2014

ProsFit - 200k in 2014


N/C


200,000





N/C

Luke is part of the investment team

conducting origination, due diligence,

deal structuring and portfolio

management at Reed Elsevier Ventures.

Prior to joining Reed Elsevier Ventures

Luke was part of the strategy consultancy

Oliver Wyman, working across the

healthcare, retail, aviation and consumer

goods sectors.

Luke holds a Bachelor of Science degree

in Natural Sciences from the University of

Durham and a PhD in Biochemistry from

St Edmunds College, Cambridge.

Luke SMITH

Investment Associate

Reed Elsevier Venture

United Kingdom


in digital health

Jointly Health - Remote patient

monitoring platform - 2014

Tigertext - Secure messaging

platform for physicians - 2013

Activate Networks - Network

analysis for healthcare providers

and pharma companies – 2012


600,000


1,000,000











Pierre is an early stage tech investor

focused on healthcare IT, medtech,

internet of things, cyber security and

cloud computing. Prior to joining ACPL, he

guided Avesthagen's global strategy and

European activities, raised US$ 120 mn

and led two dozen transactions including

acquisitions, joint-ventures and exits.

Pierre started his career as an auditor

with KPMG. He subsequently worked as a

financial engineer at Natixis and as a

research fellow in environmental

econometrics where he focused on

health microeconometrics.

Pierre SOCHA

Investment Manager

Amadeus Capital

Partners

United Kingdom


in digital health

Digital health: TrialReach, Qinec.

Medtech: Axol, Organox, Sphere

Fluidics, Base4 Innovation, Bellco,

Optos, Glysure, Solexa, Ciphergen.


100,000


1,500,000










● Search

● Content

● Gaming

● Wellness

● Provider Search














Sebastian is passionate about

technology. At Reed Elsevier Ventures he

carries out analyses and research of the

American and European technology

market to identify new and innovative

start-ups at an early stage. Relevant

areas are big data & analytics, mobile

technology, media and healthcare.In his

previous role, Sebastian built and led the

data team at SwiftKey, a successful

language technology start-up based in

London. He primarily worked on analytics,

cloud computing, data modelling and

integration.

Sebastian SPIEGLER

Associate

Reed Elsevier Ventures


in digital health

Healthline

Treato

Inpharmatica

Sentrian


1,000,000


10,000,000



Diagnostic Testing



●Search

●Provider Search













Philip Stadtmann works for DocCheck in

different positions, amongst them as

member of the board of DocCheck Guano

AG.

Philip STADTMANN

Director

DocCheck Guano AG

Germany


in digital health

Guano AG is a seed investor at

betterdoc.org and will close

more investments. Guano AG

hosted MESH Camp 2014 where

numerous start-ups from the

health sector met in Berlin.


25,000


500,000



Diagnostic Testing

●· Patient Communities

●· Content

● Provider Search


●· Professional Knowledge Exchange




●· Patient Provider Communication







Klaus Stoeckemann is a co-founder and

Managing Partner of Peppermint

VenturePartners (PVP). PVP focuses on

investments in medical device and digital-

health start-up companies in Europe. As a

former General Partner in the 3i

Healthcare Venture Capital (VC) team, he

is a highly experienced VC with more than

14 years of experience. He is currently

chairman of the boards of Humedics,

Emperra E-Health Technologies as well as

Caterna Vision both digital health care

companies and board member of

Implandata.

Klaus STOECKEMANN

Managing Partners

Peppermint

VenturePartners

Germany


in digital health

Carterna Vision

(www.carterna.de): Digital

Thearpy for treatment Amblyopia

Emperra E-Health Gmbh

Technologies

(www.emperra.com): Digital

Solution for diabetes


250,000


2,600,000






● Content

● Gaming









Prior to founding Faraday Venture

Partners, Gonzalo worked in the M&A

department of KPMG, in the risk

management department of Ecofin Ltd.

(Hedge Fund / Private Equity), as

technology consultant for alternative

investment funds at Beauchamp

Financial Technology Ltd. and as auditor

for alternative investment funds at

PricewaterhouseCoopers LLC. Gonzalo is

a Chartered Financial Analyst with a

Degree in Economics and an MSc in

International Finance.

Gonzalo TRADACETE

Co-founder & CEO

Faraday Venture

Partners

Spain


in digital health


100,000


500,000







Diagnostic Testing


●Content

●Gaming

●Wellness







in digital health

With over €100 million in total

commitments under management,

NBGI Ventures is based in London and

considers investments across Europe

and the U.S. Companies it has

supported to date include Advanced

Cardiac Therapeutics, BoneSupport,

Cellnovo, DySIS Medical, EOS Imaging,

Estech, Quanta Fluid Solutions,

Reverse Medical, SuperSonic Imagine,

Symetis, Technolas/2010 Perfect

Vision and Upfront Chromatography.

NBGI Ventures is a division of NBGI

Private Equity Limited, which is

authorized and regulated by the

Financial Conduct Authority.

Minimum ticket amount (in €) : N/C

Maximum ticket amount (in €) : N/C

James WONG

Investment Manager

NBGI Ventures (NBGI

Private Equity Ltd)

United Kingdom





Diagnostic Testing





● Search

● Content

● Gaming

● Wellness

● Provider Search











Analytics




NBGI Ventures, established in 2001, is

the only European venture capital fund

investing exclusively in medical device

companies. With over €100 million in

total commitments under management,

NBGI Ventures is based in London and

considers investments across Europe and

the U.S.

Documents

Mario Alberto ACCARDI · 2015-11-13 · Mario Alberto ACCARDI Associate Entrepreneurs Fund Management United Kingdom Previous investments in digital health Minimum ticket amount (in